Basic information Safety Supplier Related

Pipequaline

Basic information Safety Supplier Related

Pipequaline Basic information

Product Name:
Pipequaline
Synonyms:
  • Pipequaline
  • PK-8165; PK8165; PK 8165
  • 2-phenyl-4-(2-piperidin-4-ylethyl)quinoline
  • CAS_77472-98-1
  • 2-Phenyl-4-[2-(4-piperidinyl)ethyl]quinoline
  • 45319RP
  • PK-8165
  • RP-45319
CAS:
77472-98-1
MF:
C22H24N2
MW:
316.44
Mol File:
77472-98-1.mol
More
Less

Pipequaline Chemical Properties

Boiling point:
489.2±30.0 °C(Predicted)
Density 
1.078±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 10 mg/ml; DMSO: 20 mg/ml; DMSO:PBS (pH 7.2)(1:5): 0.16 mg/ml
form 
A crystalline solid
pka
10.60±0.10(Predicted)
color 
White to off-white
More
Less

Pipequaline Usage And Synthesis

Description

Pipequaline is a partial agonist of central benzodiazepine receptors (Ki = 78 nM in a radioligand binding assay). In mice, pipequaline enhances the effects of diazepam , further reducing foot shock-induced fighting behavior and the number of maximal electroshock-induced seizures and potentiating the muscle relaxant and hypnotic effects. Pipequaline also increases drinking in the Vogel punished drinking task indicating anxiolytic-like activity that can be reversed by the benzodiazepine receptor antagonist flumazenil .

Uses

Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity[1][2].

in vivo

Intravenously administered pipequaline exerts a partial suppression of activations by kainate, glutamate and acetylcholine. Microiontophoretic applications of pipequaline reduces the neuronal activation by kainate[2]. Pipequaline produces dose-related decreases in motor activity. Pipequaline produces significant dose-related decreases in the number of head-dips made[3].

References

[1] Bradwejn J, et al. Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-inducedactivation of hippocampal pyramidal neurons: a microiontophoretic study in the rat. Eur J Pharmacol. 1985 Jun 19;112(3):415-8. DOI:10.1016/0014-2999(85)90790-3
[2] Debonnel G, et al. Pipequaline acts as a partial agonist of benzodiazepine receptors: an electrophysiological study in the hippocampus of the rat. Neuropharmacology. 1987 Sep;26(9):1337-42. DOI:10.1016/0028-3908(87)90096-7

PipequalineSupplier

Guangzhou Zhiya Chemdrugs Co.,Ltd
Tel
18122150900
Email
sculk28@163.com
ELSA BIOTECHNOLOGY CO.,LTD.
Tel
15261860116
Email
sales@elsa-biotech.com
Borenpharm Co., Ltd
Tel
027-65563561
Email
sales@borenpharm.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Email
2853530910@QQ.com